...OGen-mutations identifies cancer drivers across tumor types. Nat Methods 10: 1081–1082. ↵Grey C, Clément JAJ, Buard J,
Leblanc B, Gut I, Gut M, Duret L, de Massy B. 2017. In vivo binding of PRDM9 reveals interactions with noncanonical genomic sites. Genome Res 27: 580–590. ↵Hagstrom SA, Dryja TP. 1999. Mitotic...